-35%

est. 2Y upside i

HealthcareSeries B

Customer data collection, safeguarding, & activation for healthcare

Rank

#879

Sector

Healthcare Privacy Platform

Est. Liquidity

~4Y

Data Quality

Data: Medium

Freshpaint presents a moderate upside opportunity for a job seeker.

Last updated: March 10, 2026

Bull (23%)+300%

Freshpaint successfully expands its platform beyond marketing to broader healthcare data activation, securing major enterprise clients like large hospital systems and health insurers. This market expansion, coupled with continued regulatory tailwinds favoring specialized privacy solutions, drives revenue to over $100M by 2028 and justifies a $980M valuation at exit, representing a 4x return on current valuation.

Base (50%)+75%

Freshpaint maintains its strong niche in HIPAA-compliant healthcare marketing data, growing steadily at 15-20% YoY by expanding its customer base within its SAM. It fends off generalist CDP competitors due to its specialized compliance features. This leads to an acquisition by a larger healthcare tech or marketing platform company at a valuation of approximately $429M, a 1.75x return.

Bear (27%)-50%

Dominant healthcare incumbents like Epic or Cerner, or a well-funded generalist CDP, launch a directly competing HIPAA-compliant marketing data solution, eroding Freshpaint's market share. The company struggles to accelerate its current ~9% YoY growth, leading to a down round or an acquisition at a significantly reduced valuation of $122.5M, wiping out half of the current equity value for common shareholders.

Est. time to liquidity~3.5 years

Preference Stack Risk

high

Investors hold $41.9M in liquidation preferences. In an exit at or below $245M, common stock value would be significantly impacted, potentially receiving nothing if the exit is below $41.9M.

Dilution Risk

moderate

As a Series B company, Freshpaint will likely need at least one more significant funding round before an exit, which will cause further dilution for existing equity holders.

Secondary Liquidity

limited

Forge indicates limited market activity and specialists available for selling shares, suggesting some but not active secondary liquidity.

Engineering — 4 roles

Customer Success — 2 roles

Product — 2 roles

Sales — 1 role

View all 9 open roles at Freshpaint →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Freshpaint's data — designed to show you've done your homework.

  • 1

    “Given the 'medium' incumbent threat from large healthcare players like Epic and Cerner, how is Freshpaint planning to maintain its competitive edge and prevent these giants from building or acquiring similar HIPAA-compliant marketing solutions?”

  • 2

    “The company achieved 10x revenue growth in 2023, but the current YoY growth is stated as ~9%. Can you elaborate on the factors contributing to this shift and the strategy to re-accelerate growth in the coming years?”

  • 3

    “With a Series B funding round completed and a current valuation of $245M, what is the anticipated timeline and strategy for a liquidity event for employees, and what are the company's plans for future funding rounds?”

Community

Valuation Sentiment

Our model estimates -35% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.